Is there a cost-effective way to diagnose mild sleep-disordered breathing?  by BACHOUR, A. et al.
Vol.96 (2002) 586^593Is there a cost-e¡ectiveway to diagnose
mild sleep-disorderedbreathing?
A.BACHOUR*, J.HERRALAw, P.MAASILTA*
*Department of Pulmonary Medicine,Helsinki University Central Hospital, Finland and wDepartment of Pulmonary
Medicine,Tampere University Hospital, Finland
Abstract Question ofthe study:Todeterminetheutilityandthecost-effectivenessofoesophagealpressure,respiratory
flow andmovement, and oximetry (ORO) as a diagnostic tool formild sleep-disordered breathing (SDB), as compared
with overnightpolysomnography (PSG).
Patients andmethods: Seventy-nine patients evaluated formild SDB by PSG and simultaneously byoesophageal pres-
sure (Pes) measurement, oximetry, respiratory flow and respiratorymovementon a single night. An oesophageal event
(OE)wasdefinedasirregularrespirationwithcrescendoin Pes andrapidreturntobaselinewith aminimalincreaseinthe
negative Pes atthe endofthe OEof at least 5 cmH2Oormore than 50% ofthe baseline level.SDBwas definedby ORO
when oesophageal events were45/h, and by PSGwhen the respiratory disturbance index was45/h.The diagnostic
accuracy and cost-effectiveness of OROwere comparedwith PSG.
Results: Althoughthe abilityof OROto detect SDBwaspoor: sensitivity 64%, specificity 78%, use of ORO for screen-
ingprior to PSGwouldhave saved 5000 EURper100 patients compared to initial PSG.
Conclusion:Using the combination of oesophageal pressure, respiratory flow andmovement and oximetry for the diag-
nosis ofmild SDBisnotcost-effective, because of itspoordiagnostic accuracy.Newdeviceshavingalternativemeans topre-
dict arousal andrespiratoryeffort variation shouldbe evaluated forcost-effectiveness.r2002 Publishedby Elsevier Science Ltd
doi:10.1053/rmed.2002.1306, available online athttp://www.idealibrary.comon
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Sleep-disordered breathing (SDB), a disorder syndrome
associatedwith repetitive apnoeas and hypopnoeas dur-
ing sleep with oxygen desaturations, sleep fragmenta-
tion, and daytime sleepiness, has been estimated to
a¡ect 2^4% of the adult middle-aged population (1). Un-
treated SDB has several consequences, such as an in-
creased risk for motor vehicle accidents (2). Even in
subjects with mild forms of SDB, with the respiratory
disturbance index (RDI) at 45/h, hypertension, sleepi-
ness, and motor vehicle accidents may occur (3). Mean-
while, in a recent cross-sectional study (4), SDB showed
a modest-to-moderate e¡ect on various manifestations
of cardiovascular diseases, within a range of apnoea and
hypopnoea index values considered normal or only
mildly elevated. In addition, patients with undiagnosed
SDB had considerably higher medical costs than did age-
and sex-matched individuals without SDB (5), and treat-Received 20December 2001, accepted inrevised form5 February 2002.
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Finland.Fax: +358 9 47174020; E-mail: adel.bachour@hus.¢ment with continuous positive airway pressure improve
the patients’ symptoms even inmild cases (6).
As sleep monitoring is expensive and resource inten-
sive, several studies have considered alternativemethods
and revealed that the diagnosis of moderate and severe
SDB canbemade by nocturnal oximetry alone (7^9), but
the diagnosis of mild forms requires overnight polysom-
nography (PSG) that includesmonitoring of sleep as well
as of breathing. Yamashiro et al. (10), in fact, found that
30% of patients considered normal by oximetry alone
had amild formof SDB on PSG. In addition, several other
studies (11,12) using nocturnal oximetry for the diagnosis
of SDB and showing low speci¢city values did not take
into accountmilder forms of the disease, and concluded
that all abnormal oximetryresults required PSG for con-
¢rmation.
Patients with a mild form of SDB usually present with
variable degrees of oxygen desaturation episodes, few
apnoeas or hypopnoeas and several sequences of breaths
characterised by increasing respiratory e¡ort leading to
arousal (RERA). Measurement of oesophageal pressure
(Pes) with continuous overnight monitoring is the refer-
ence standard for measuring respiratory e¡ort. No
other technique has demonstrated su⁄cient accuracy
DIAGNOSISOFMILDSLEEP-DISORDEREDBREATHING 587and precision, or has shown a correlation with clinically
important outcomes (13).
As sleep monitoring is the most expensive and re-
source-intensive part of overnight polysomnography, we
selected oesophageal pressure, respiratory movements
and air£ow, and oximetry (ORO) and studied this hy-
pothetical system in the diagnosis of mild sleep-disor-
dered breathing (SDB). We report here the diagnostic
accuracy and cost-e¡ectiveness ofORO for thediagnosis
ofmild SDB comparedwith those of PSG.
PATIENTS
We reviewed the sleep studies of consecutive patients
referred for evaluation of possible mild SDB who under-
went PSGwith measurement of Pes in our sleep labora-
tory from 1998 to 2000. Mild SDB was clinically
suspected in patients with mild-to-moderate excessive
daytime sleepiness and a history of snoring. A recording
with the oesophageal catheter was started in 88 pa-
tients; 79 slept more than 2h with the oesophageal ca-
theter and were included in this study. We studied 51
men and 28women,mean (SD) age 49 (10) years, neck cir-
cumference 39 (4) cm, and body mass index (BMI) 28
(5) kg/m2 (Table1).
METHODS
The severity of daytime sleepiness was evaluated by the
Epwroth sleepiness scale (14) (ESS) and classi¢ed clini-
cally according to AASMrecommendations (13).
Polysomnographies were performed with a compu-
terised 24-channel polygraph (Alice 3, HealthdyneTech-
nologies, Marletta, GA, U.S.A.). This included a four-
channel electroencephalogram (C3A2, C4A1, O1A2 and
O2A1), electro-oculogram, and submental and leg elec-
tromyogram. Heart rate was monitored through stan-
dard leads. Air£ow was monitored by a nasal and oral
thermistor. Thoracic and abdominal belts (HealthdyneTABLE 1. Patients’characteristics and data frompolysomnogra
BMI
(kg/m2)
Age
(year)
ESS TIB
(min)
TST
(min)
Se¡
(%)
Delta
(%)
RE
(%
Mean 28 49 9 458 345 75 16 18
SD 5 10 4 50 87 15 9 8
Maximum 45 73 17 542 507 98 34 35
Minimum 19 25 2 268 138 33 0 0
Note: ORO=Oesophageal pressure, respiratory £ow andmo
sleepiness scale,TIB=time in bed with oesophageal cathether;
sleep,REM=% of rapid eye movement sleep; ODI4=oxygen des
TIB,CO246 kPa=% of time in bedwhen ETCO246 kPa;RERA
arousal index,RDI=respiratorydisturbance index;OI=oesophapiezo e¡ort sensor) were used for respiratory move-
ment detection. Pulse oximetry and nasal expired CO2
were monitored by (BCI Capnochec plus, BCI Interna-
tional, Waukesha, WI, U.S.A.). Oesophageal pressure
was monitored by a piezoresistor pressure sensor (Sy-
nectics FTC catheter, French size F8/2,7mm. Synectics
Medical AB, Stockholm, Sweden) with a sampling rate
at 40Hz.The oesophageal catheter was calibrated regu-
larly, inserted through the nose after local anaesthesia
and ¢xed about 38cm from the nostril.This manoeuvre
was abandoned if the patient complained of discomfort.
The catheter was removed during the recording when
requested by the patient. A nurse trained in sleepmedi-
cine attended the polysomnography.
Sleepwasmanually scored in epochs of 30 s according
to Rechtscha¡en and Kales criteria (15). An arousal was
de¢ned by an EEG frequency shift into the alpha range
for at least 3 s (16). An apnoeic event was de¢ned as ces-
sation of nasal/oral air£ow for at least 10 s without re-
gard to either arousal or oxygen desaturation, while a
hypopnoea was de¢ned as a450% decrement in nasal/
oral air£ow for at least 10 s, associated with either an
arousal or oxygen desaturation3%.
Respiratory e¡ort-related arousal (RERA) events
were scored according to AASM recommendations (13).
An RERA event was scored when it was not caused by
apnoea or hypopnoea, it lasted10 s or longer with a pat-
tern of progressively more negative oesophageal pres-
sure, and was terminated by a sudden change in
pressure to a less negative level and an arousal (Fig.1).
The respiratory disturbance index RDI was calculated
by the following formula: number of apnoeas+hypop-
noeas+RERAs/total sleep time (h).
An oesophageal event was registered when a pattern
of progressively more negative oesophageal pressure
lasted for10 s or longer and ended with a sudden return
to the baseline, regardless of whether it was associated
with apnoea or hypopnoea (Fig. 2).Theminimal increase
in the negative oesophageal pressure at the end of the
oesophageal event was at least 5 cm H2O or more thanphyand fromORO
M
)
ODI4
(/h)
ETCO2
(kPa)
CO246 kPa
(%)
RERA
(/h)
Arousal
(/h)
RDI
(/h)
OI
(/h)
10 5.8 33 3.4 15 8.2 5.6
10 0.5 30 2.3 7 5.6 6.0
44 6.8 95 10.6 38 26.5 30
0 4.4 0 0.0 5 0.4 0.0
vement and oximetry;BMI=bodymass index; ESS=Epworth
TST=total sleep time; S.e¡=sleep e⁄ciency; delta=% of delta
aturation index of 4%; ETCO2=mean of end tidal CO2 during
=respiratorye¡ort-related arousalper sleep hour; Arousal =
geal index; SD=standard deviation.
FIG. 1. Example of a respiratorye¡ort-related arousal (RERA): a patternof progressivelymorenegative oesophagealpressure, terminatedbya suddenchange inpressure to a lessnegative
level and arousal. Abbreviations: light=light intensity (from 0 to 50),LEOG=left oculogram;REOG=right oculogram; Chin=submental electromyogram; Esophag=oesophageal pressure;
Nose=nasal air£ow;Mouth=mouth air£ow;ABD=abdominalrespiratorymovement.THO=thoracic respiratorymovement;Micro=snoring;G SaO2=SpO2 graphicalcurve;EtCO2=end-
tidal CO2;GCO2=graphical curve of ETCO2;Body=bodyposition; S=supine.
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FIG. 2. Example of an oesophageal event: a pattern of progressivelymore negative oesophageal pressure lasting for410 s and ter-
minated by a sudden change in pressure to a less negative level, regardless of whether it was associatedwith apnoea or hypopnoea.
Abbreviations:Esoph=oesophagealpressure;Nose=nasal air£ow;Mouth=mouth air£ow; ABD=abdominalrespiratorymovement;
THO=thoracic respiratorymovement;G SaO2=SpO2 graphical curve.
DIAGNOSISOFMILDSLEEP-DISORDEREDBREATHING 58950% of the baseline level. Oximetry was used to guide
the observer to respiratory events but no minimal drop
in oxygen saturation was used for scoring oesophageal
event.Oesophageal index (OI) was calculated by the fol-
lowing formula: number of oesophageal events/total
time in bed (h).
Sleep e⁄ciency (Se¡) was calculated by the following
formula: total sleep time 100/time in bed.During time
in bed (TIB), the following parameters were calculated
automatically and validated by a chest physician trained
in sleep medicine: mean end tidal CO2 (ETCO2), percen-
tage of recording time spend when ETCO246kPa, and
oxygen desaturation episodes of 4%/h (ODI4).
PROTOCOL
Data analysis
PSG recordings were scored manually by a chest physi-
cian trained in sleepmedicine.The diagnosis of sleep-dis-
ordered breathing (SDB) was made when the RDI on
PSG was 45/h. From the same polysomnography re-
cording only oesophageal pressure, respiratory £ow andmovement and oximetry (ORO)weremade available for
manual scoring to another chest physician trained in
sleep medicine, who was blinded to the PSG results but
did have access to the patient’s ¢le.The diagnosis of SDB
wasmadewhen the oesophageal index (OI) for theORO
systemwas45/h.
Cost analysis
Two diagnostic algorithms were compared by use of the
data from the initial PSGs and OROs. In the ¢rst algo-
rithm, ORO served as the initial screening test, and all
patients with abnormal ORO (OI45/h) results went on
to PSG forde¢nitive diagnosis.For the second algorithm,
all patients had an initial PSG. In both algorithms, all pa-
tients diagnosed as having SDB underwent a one-night
CPAP titration for treatment (Fig. 3).During PSG, the ad-
ditional cost ofmonitoring oesophageal pressurewas es-
timated to be equivalent to the additional cost causedby
CPAP titration. The cost reported for ORO was 250
EUR; the costs for interpreted PSGwith CPAP titration
or with oesophageal pressure monitoring amounted to
400 EUR, total.
normal
42 subjects
normal
7 subjects
CPAP titration
SDB
30 subjects
PGS
SDB
37 subjects
Initial ORO
Algorithm A
normal
32 subjects
CPAP titration
SDB
47 subjects
Initial PSG
Algorithm B
FIG. 3. Diagnostic decisiontree.Algorithm Awith OROas the initial screening test.Algorithm Bwith PSGas the initial test.
TABLE 2. Diagnostic accuracyof ORO fordetectingmild SDB
BMI (kg/m2)
All subjects o30 430
Subjects 79 54 25
Sensitivity(%) 64 65 63
Speci¢city (%) 78 78 78
Positive predictive value (%) 81 80 83
Negative predictive value (%) 60 62 54
Note:ORO=oesophagealpressure, respiratory £owandmovement and oximetry;BMIbodymass index.
590 RESPIRATORYMEDICINEStatistical analysis
For the evaluation of the diagnostic accuracyofOROwe
used overnight PSG as the gold standard.We evaluated
the sensitivity (true positive/[true positive+false nega-
tive]), the speci¢city (true negative/[true negative+false
positive]), the positive predictive value (true positive/
[true positive+false positive]), and the negative predic-
tive value (true negative/[true negative+false negative]).
We also drew a receiver-operating curve (ROC) for
ORO in the detection of SDB with a value OI between
0.2 and 30.When needed, we used the Student’s t-test
to compare a subgroupwith all the subjects.
RESULTS
In 47 of the 79 patients, a diagnosis of SDBwas made by
PSG,with ameanRDI (SD) of 8.2 (5.6) (Table1).The ability
ofORO to detect SDBvaried according to the diagnostic
criteria used. For an OI of 5/h, sensitivity was 64%, spe-ci¢city 78%, positive predictive value 81%, and negative
predictive value 60%.This accuracy did not di¡er signi¢-
cantly between obese and non-obese subjects (Table 2).
With a variable diagnostic criterion of OI ranging from
0.2 to 30, the sensitivity decreased from 96 to 0%, and
the speci¢city increased from 6 to100% (Fig. 4).
All patients sleptmore than120min, with amean time
in bed TIB (SD) of 458 (50)min, total sleep timeTST 345
(87)min, sleep e⁄ciency 75 (15)%, delta sleep 16 (9)% of
TST, REM sleep 18 (8)% of TST, ETCO2 5.8 (0.5)kpa and
ETCO246kPa 33 (30)% of TIB (Table1).
Cost analysis
In the ¢rst hypothetical algorithm, ORO served as the
initial screening test.Of the 79 subjects, 37 had abnormal
ORO (OI45/h) results andwenton to PSG forde¢nitive
diagnosis.Of these 37, 30 had SDB andunderwent aCPAP
titration trial. For the second hypothetical algorithm, all
patients had an initial PSG; 47 had mild SDB and under-
went a CPAP titration trial (Fig. 3).
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FIG. 4. Receiver operating curve of ORO using an oesopha-
geal indexbetween 0.2 and 30/h fordiagnosis ofmild SDB.
DIAGNOSISOFMILDSLEEP-DISORDEREDBREATHING 591The cost of ORO as a screening test for the diagnosis
of mild SDB was 59.000 EUR and for the algorithmwith
PSG as the initial test 64.000 EUR. Use of ORO as a
screening test prior to PSG, rather than initial PSG test-
ing, would have saved 5.000 EUR per100 patients evalu-
ated, if all patientswithmild SDB had required a second-
night study for CPAP titration.
Although this method reduced costs, 17 of the 42 pa-
tients with normal ORO results hadmild SDB missed by
screening ORO alone; their age was a mean 51.8, BMI
29.3, RDI 9.0, RERA 5.2, and AI 1.5.We found no signi¢-
cant di¡erence (P40.05) in these variables between
these patients and thewhole population.
DISCUSSION
Our study con¢rms the ¢ndings of previous studies that
PSGis still necessary for the diagnosis ofmild SDB (8^10,
12). Applying a diagnostic algorithm utilising ORO as a
screening tool to guide decisions on which patients
should undergo PSG did result in small cost savings com-
pared to use of PSG alone.However, the consequence of
ORO for screening was that a signi¢cant number of pa-
tients with sleep disorders that cause excessive sleepi-
ness would have remained undiagnosed and untreated.
The high cost of sleepiness-relatedmotor vehicle, work-
related, and home-based accidents could negate these
small cost savings (17).
We report the cost-e¡ectiveness according to the
cost in our university hospital. Prices in Finland could
vary between public health centres up to 30% because
of a decentralised health policy. In France, the estimated
real cost for an overnight polysomnography in a univer-
sity hospital in Paris, is at 500 EUR,meanwhile thepublic
health insurance considers the cost at only 150 EUR. In
addition, prices of health-care services within Europecould vary signi¢cantly. Nevertheless, this variation
would not change the conclusion of this study, as the in-
crease in the saving, induced by the use of ORO, in an
expensive health-care systemwouldbe counterbalanced
by the increase in the cost induced by the sleepiness-re-
latedmotor vehicle accidents.
There are some likely explanations for the failure of
ORO to recognise SDB in some patients. Poor Pes mon-
itoringmay disturb the scoring of an oesophageal event.
In fact, it is known that the quality of Pes monitoring is
related to the position of the pressure sensor in the oe-
sophageal lumen and also to the patient’s position. Poor
quality Pes data during a portion of the recording have
been found in18 out of 40 study patients (18). In addition,
the respiratory e¡ort in response to upper airway occlu-
sion in SDB patients is reported to be lower in REM than
in non-REM sleep and decreases with increasing age (19).
Meanwhile, a globalreduction in Pes swings is usually pre-
sent in obese patients.Our patients had a wide range of
age and of BMI in addition to the varying amount of REM
sleep. Although obesity may reduce the Pes swings, we
found that the accuracy of ORO in detecting SDB was
low in both obese and non-obese subjects.
Di⁄culties in scoring oesophageal events and RERAs
may lead to underestimation. This risk of underestima-
tion has little e¡ect on RDI, as apnoeas and hypopnoeas
are scored regardless of Pes swings. It is known that Pes
swings are more prominent during obstructive apnoea
thanduring a respiratoryeventwithpartialupper airway
obstruction. Patients withmild SDBmay havemore par-
tial obstructions than real obstructive apnoeas. Mean-
while, the presence of an arousal at the end of a
respiratory event with partial obstructionmay alert the
physician to the importance of this respiratory event,
therefore, such small Pes swings are scored as RERAs in
polysomnography but probablymissed in ORO.
As it is logical to expect that OI is higher than RERA
index, we found a few discrepancies in some patients be-
tween OI and RERA.This is due in part to the di¡erence
in their sleep e⁄ciency.Weused TIB as a denominator to
calculate OI whereasTSTwas used for RDI.This will lead
to a decrease in OI for the same number of respiratory
events. In addition, as there is no general agreement for
the exactde¢nition of anOEwemay havemissed a small
number of respiratory eventswith amild variation in oe-
sophageal pressure but this variation may have been suf-
¢cient to induce an arousal.
We did not correct OI in relation to sleep e⁄ciency.
This correction will increase the threshold of normality
of OI tomore than 5/h.Nevertheless, evenwith a higher
OI threshold, the sensitivity and speci¢cityofOROinde-
tecting OSAwould still be below acceptable values for a
screening test.
We used thermistors for measuring air£ow. Thermis-
tors are known to give a measure more qualitative than
quantitative (20); Nevertheless, for detecting apnoeas,
592 RESPIRATORYMEDICINEthey have good validity, whereas problems mount in de-
tecting hypopnoeas (13). Because we monitored Pes at
the same time, the hypopnoea potentially missed by
thermistors wouldbe scored as RERA in PSG, therefore
having the ¢nal value of RDI una¡ected.
We found a high rate of RERAs in relation to respira-
tory events, whereas Cracowski et al. (21), recently re-
ported a low rate of RERAs in mild-to-moderate sleep
disordered breathing syndrome.They used a pneumota-
chograph formeasuring respiratory £ow and considered
a threshold of 30% as a minimal £ow reduction for scor-
ing a hypopnoea.This will lead to an increase in hypop-
noeas and a decrease in RERAs.
A recent study (22) reported an interobserver varia-
bilityof 29.7% in the detection of respiratorye¡ortby Pes
monitoring. In our study, we did notmeasure interobser-
ver variability. We calculated the sensitivity of ORO in
detecting mild SDB at 64%. This implies that factors
other than interobserver variability are likely to account
for the results observed. In addition, as it is usual to ¢nd a
relatively low concordance between di¡erent scorers
when scoring only one channel (23), we made oximetry
available also to the observer of ORO, as desaturation is
easy to recognise.
Oximetry is known as an easy and low-cost tool for
screening SDB. Nevertheless, a minimal oxygen drop
was not included in the diagnostic criteria of OE, as we
aimed to increase the sensitivity in scoring OE by recog-
nising respiratory events that are not associated with a
drop in oxygen saturation. These respiratory events
without a drop in oxygen saturation are usually frequent
in young subjects with short respiratory events and
healthy lungs.
We found that ETCO2 had a tendency to rise in pa-
tientswithmild SDB and also during simple snoring. This
may rise the question of the e¡ects of such rise in this
group of patients.
We tried to ¢nd diagnostic method to serve as an al-
ternative to polysomnography in patients with a suspi-
cion of mild SDB. In this particular group of patients,
diagnosis requires the monitoring of respiratory e¡ort
with an accurate device. Several studies that did not in-
clude Pes monitoring failed to recognise mild SDB
(11,12,24).Our results agree with Ross et al. (25) that al-
ternativemethods of diagnosis of OSA have provided in-
su⁄cient evidence to allow their recommendation
instead of full polysomnography. Nevertheless, the use
of pulse transit time for measuring respiratory e¡ort
seems to be promising (22).
Pes monitoring, although regarded as the gold stan-
dard for measuring respiratory e¡ort (13), is, however,
not without drawbacks. It is invasive, often uncomforta-
ble for thepatient, andmaynotbe tolerated. In addition,
evidence exists that an oesophageal cathetermaymodify
pharyngeal airway dynamics (26), and it has been sug-
gested that its presence may itself impair the quality ofsleep (27), though this is still disputed (28).Weused a so-
lid-state piezoresistor pressure sensor with a high sam-
pling rate.The catheter is easy to calibrate and has good
reproducibility (29). To the best of our knowledge, we
found no study in patients with mild SBD comparing the
use of a catheter with piezoresistor pressure sensor to
the use of the classical rubber balloon sensor. Neverthe-
less, several sleep centres use similar solid-state sensor
catheter (26,30,31), as well as, medical centres using am-
bulatory oesophagealmanometry (29).
Our study of patients with excessive daytime sleepi-
ness and a suspicion of mild SDB, only about half had
SDB by PSG.This agrees with Rowley’s report (32) that
a clinician’s subjective impression or theuse ofprediction
models is not su⁄ciently accurate to discriminate be-
tween patients with or without SDB.
We conclude that the combination of oesophageal
pressure, respiratory £ow andmovement, and oximetry
for the diagnosis of mild SDB is not cost-e¡ective be-
cause of its poor diagnostic accuracy.Our results empha-
sise the role of overnight polysomnography in such
diagnosis.Newdeviceswith alternativemeans of predict-
ing arousal and respiratory e¡ort variation, like pulse
transit time and nasal pressure measurement, should be
evaluated for cost-e¡ectiveness in screening for mild
SDB.
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